SCHEMBL6160971

SCHEMBL6160971

O=C(O)Nc1ccc(OC(F)(F)F)c(Br)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 4/20 0.55
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
TRPV1 Q8NER1 1/20 0.43
KCNK3 O14649 4/20 0.43
KCNK9 Q9NPC2 4/20 0.43
PNLIP P16233 1/20 0.42
GSTO1 P78417 1/20 0.41
MAPT P10636 2/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
ALDH1A1 P00352 3/20 0.40
GAA P10253 2/20 0.40
POLB P06746 1/20 0.40
THRB P10828 1/20 0.40
KDR P35968 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5804037 0.88 CYP1A2 (0.59) EPHX2CYP1A2CYP2C9CYP2C19HTR2A
SCHEMBL15168933 0.88 EPHX2 (0.51) EPHX2CYP1A2CYP2C9CYP2C19HTR2A
SCHEMBL4855842 0.86 ALDH1A1 (0.55) EPHX2CYP1A2CYP2C9CYP2C19HTR2A
SCHEMBL23088133 0.83 EPHX2 (0.79) EPHX2CYP1A2CYP2C9CYP2C19KDR
SCHEMBL28526013 0.81 TDP1 (0.58) EPHX2CYP1A2CYP2C9CYP2C19HTR2A
SCHEMBL2347463 0.81 EPHX2 (0.49) EPHX2CYP1A2CYP2C9CYP2C19HTR2A
SCHEMBL28526011 0.80 EPHX2 (0.48) EPHX2CYP1A2CYP2C9CYP2C19HTR2A
Fluoride SCHEMBL11789657 0.80 EPHX2 (0.54) EPHX2PNLIPMAPTKMT2AMEN1
SCHEMBL2635423 0.79 EPHX2 (0.60) EPHX2CYP1A2CYP2C9CYP2C19KCNK3
SCHEMBL5914904 0.78 DHODH (0.57) EPHX2CYP1A2CYP2C9KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1558582-B1 DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2005-12-21 EP disclosed